Second American With Rare Ebola Strain Treated in Germany After DRC Infection

Evacuation and Treatment in Frankfurt

The transfer was coordinated by the U.S. State Department, marking the second time in recent months an American humanitarian worker has been flown to Germany for specialized care following an Ebola diagnosis in the DRC.

“The patient’s condition is currently stable,”

Timo Wolf, head of the special isolation unit at Frankfurt University Hospital, via Jpost

Unlike standard hospital wards, the Frankfurt facility utilizes high-security isolation protocols to prevent the spread of the virus. German health authorities, including a spokesperson for the Health Ministry, emphasized that there is no risk to the general public or other hospital patients, as the individual remains in a completely separate, secure unit, Yahoo reported.

Outbreak Scale and Resource Constraints

The current Ebola outbreak, which began on May 15, has reached 1,926 confirmed cases and 702 deaths, according to figures released by the DRC’s public health institute on Monday. The virus is identified as the Bundibugyo strain, a rare variant for which no approved vaccine or specific treatment currently exists. As Arstechnica noted, the outbreak is already the third largest on record and continues to spread into new provinces, including Haut-Uele and Tshopo.

International health officials have expressed significant concern regarding the speed of the transmission. Dr. Marie-Roseline Belizaire, a World Health Organization (WHO) incident manager, told CBS News that the response is currently hindered by undetected cases. “One month after the outbreak has been declared, I’m still feeling concerned,” she said, noting that responders are “missing cases” as the virus moves through the population, as reported by Forbes.

Funding and International Response

The financial requirements to contain the virus have escalated sharply. Africa CDC Director-General Jean Kaseya recently warned that an estimated $1.4 billion is necessary to resolve the humanitarian crisis and halt the outbreak. While the White House has submitted a supplemental funding request to Congress to address this, critics have pointed to recent cuts to U.S. foreign aid and public health infrastructure as a complicating factor, NBC News reported.

Meanwhile, the University of Oxford has launched an early-stage human trial for a vaccine candidate, known as BD-Ebov, which utilizes the same viral vector platform as the Oxford/AstraZeneca COVID-19 shot. The Coalition for Epidemic Preparedness Innovations (CEPI) has committed up to $8.6 million to support the initial development of this vaccine, which is intended to provide a pathway to strengthen regional defenses against future health threats.

Controversy Over U.S. Containment Strategy

The U.S. government’s policy of transporting infected citizens to Europe rather than back to domestic facilities has drawn internal criticism. While the US has multiple facilities around the country designed to safely monitor and provide high-quality care for Ebola patients, the administration has maintained a policy of keeping the U.S. free of travelers with Ebola. Plans to build a quarantine facility in Kenya for exposed Americans have faced significant local opposition, resulting in protests and a temporary court-ordered construction pause, WTVB reported.

As of mid-July, the WHO continues to work with the Congolese government and the Africa CDC to bring the outbreak under control. Health experts continue to monitor the effectiveness of the regional treatment network and the potential for clinical trials to provide new tools for future containment.

Find more reporting in our Health section.